Eyenovia Stock Price Prediction
EYEN Stock | USD 0.11 0.02 19.05% |
Oversold Vs Overbought
45
Oversold | Overbought |
EPS Estimate Next Quarter (0.11) | EPS Estimate Current Year (0.59) | EPS Estimate Next Year (0.41) | Wall Street Target Price 3.5 | EPS Estimate Current Quarter (0.13) |
Using Eyenovia hype-based prediction, you can estimate the value of Eyenovia from the perspective of Eyenovia response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Eyenovia to buy its stock at a price that has no basis in reality. In that case, they are not buying Eyenovia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Eyenovia after-hype prediction price | USD 0.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Eyenovia |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eyenovia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eyenovia After-Hype Price Prediction Density Analysis
As far as predicting the price of Eyenovia at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eyenovia or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eyenovia, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Eyenovia Estimiated After-Hype Price Volatility
In the context of predicting Eyenovia's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eyenovia's historical news coverage. Eyenovia's after-hype downside and upside margins for the prediction period are 0.01 and 11.71, respectively. We have considered Eyenovia's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eyenovia is dangerous at this time. Analysis and calculation of next after-hype price of Eyenovia is based on 3 months time horizon.
Eyenovia Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Eyenovia is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eyenovia backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eyenovia, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.39 | 11.64 | 0.01 | 0.32 | 10 Events / Month | 4 Events / Month | In about 10 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.11 | 0.13 | 18.18 |
|
Eyenovia Hype Timeline
Eyenovia is currently traded for 0.11. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.32. Eyenovia is forecasted to increase in value after the next headline, with the price projected to jump to 0.13 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 18.18%, whereas the daily expected return is currently at -1.39%. The volatility of related hype on Eyenovia is about 5097.81%, with the expected price after the next announcement by competition of 0.43. Eyenovia currently holds 16.08 M in liabilities with Debt to Equity (D/E) ratio of 0.31, which is about average as compared to similar companies. Eyenovia has a current ratio of 2.1, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Eyenovia's use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Eyenovia Basic Forecasting Models to cross-verify your projections.Eyenovia Related Hype Analysis
Having access to credible news sources related to Eyenovia's direct competition is more important than ever and may enhance your ability to predict Eyenovia's future price movements. Getting to know how Eyenovia's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eyenovia may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
ZVSA | ZyVersa Therapeutics | (0.01) | 5 per month | 0.00 | (0.14) | 9.17 | (10.36) | 78.93 | |
SONN | Sonnet Biotherapeutics Holdings | 1.15 | 7 per month | 0.00 | (0.13) | 12.31 | (9.79) | 37.58 | |
ZURA | Zura Bio Limited | 0.03 | 9 per month | 0.00 | (0.05) | 7.95 | (7.94) | 30.69 | |
PHIO | Phio Pharmaceuticals Corp | 0.18 | 6 per month | 0.00 | (0.05) | 11.78 | (10.38) | 36.22 | |
RNAZ | Transcode Therapeutics | 0.04 | 2 per month | 6.52 | 0.07 | 22.00 | (11.43) | 68.80 | |
QNRX | Quoin Pharmaceuticals Ltd | (0.02) | 9 per month | 6.73 | 0.05 | 17.65 | (9.68) | 74.46 |
Eyenovia Additional Predictive Modules
Most predictive techniques to examine Eyenovia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eyenovia using various technical indicators. When you analyze Eyenovia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Eyenovia Predictive Indicators
The successful prediction of Eyenovia stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Eyenovia, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Eyenovia based on analysis of Eyenovia hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Eyenovia's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eyenovia's related companies. 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 56.02 | 60.2K | 54.2K | 56.9K | PTB Ratio | 5.14 | 3.18 | 9.48 | 15.46 |
Story Coverage note for Eyenovia
The number of cover stories for Eyenovia depends on current market conditions and Eyenovia's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eyenovia is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eyenovia's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Eyenovia Short Properties
Eyenovia's future price predictability will typically decrease when Eyenovia's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eyenovia often depends not only on the future outlook of the potential Eyenovia's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eyenovia's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 41 M | |
Cash And Short Term Investments | 14.8 M |
Check out Eyenovia Basic Forecasting Models to cross-verify your projections. To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.001 | Quarterly Revenue Growth 4 | Return On Assets (0.93) | Return On Equity (9.15) |
The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.